PLENARY KEYNOTE SPEAKERS

Diagnosing the Disease: Disruptive Innovation in Healthcare
Clayton M. Christensen, DBA, Robert and Jane Cizik Professor of Business Administration, Harvard Business School

Risk Diagnosis forDisease Prevention
C. Thomas Caskey, M.D., F.A.C.P., Director and Chief Executive Officer, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center

Disruption of the Pharmaceutical Industry: Moving from Products to Solutions
Elizabeth L. Bewley, MBA, Vice President, Strategic Planning, Johnson & Johnson Health Care Systems Inc.